A Phase IIa, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of the CRTh2 Antagonist AZD1981 in Patients With Chronic Idiopathic Urticaria (CIU) Who Are Refractory to H1 Antihistamines
Latest Information Update: 07 Nov 2021
At a glance
- Drugs AZD 1981 (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- 07 Mar 2016 Status changed from active, no longer recruiting to completed, according to results published.
- 07 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to the results published.
- 07 Mar 2016 Results (n=22) presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.